Deaths from influenza and pneumonia in American adults fell by 29.2 percent over a quarter century, from 63,006 in 1999 to 44,625 in 2023. Every adult age group shared in the improvement except one. Adults aged 55 to 64 were the only group with a statistically significant rise in crude death rate, at an average of 0.8 percent per year.
The finding comes from an analysis of the CDC WONDER death records by researchers in China, published in the journal Medicine and reported by CIDRAP. The national age-adjusted rate fell from 35.9 to 16.5 deaths per 100,000 residents, an average decline of 3.2 percent a year.
For most readers, the headline is reassuring, and it should be. Two respiratory conditions that once killed more than 60,000 Americans a year now kill substantially fewer, and the researchers attribute that to advances in respiratory disease prevention and to sustained investment in public health infrastructure. The exception is the part worth sitting with, because 55 to 64 is the decade when most people are least likely to see themselves as vulnerable.
The Middle-Aged Exception and What It Might Mean
People in their late fifties and early sixties occupy an awkward position in the prevention of respiratory illness. They are old enough for chronic conditions to accumulate and for immune function to begin to shift, and young enough to fall outside the age ranges most people associate with vaccination.
Several patterns would fit the finding, though the study itself establishes none of them. Rates of obesity, type 2 diabetes, and chronic obstructive pulmonary disease in this age band have climbed over the same period, and each raises the odds that a respiratory infection becomes pneumonia and that pneumonia becomes fatal. Vaccination coverage for influenza and pneumococcal disease is also consistently lower in this group than in adults over 65.
The authors do not offer a mechanism. They say directly that further research incorporating individual risk factors, vaccination data, and pathogen-specific coding is needed to clarify what is driving the trends and the disparities.
The Statistical Distinction That Changes the Story
One methodological point deserves attention because it is easy to garble, and garbling it would overstate the finding.
The 29.2 percent national decline is an age-adjusted figure, meaning it accounts for the fact that the American population grew older over the period. The rise in the 55 to 64 group is described in crude death rates, which do not adjust for age composition within the band.
That distinction matters. The baby boom cohort passed through this age range during the study window, increasing both the group's size and its average age. Some of the apparent rise could reflect that shift rather than any change in individual risk. It is a real finding worth investigating, and it is not the same as claiming that a 58-year-old today faces a higher risk than a 58-year-old in 1999.
The study carries other limits. It is an observational analysis of death certificates rather than a controlled study, so it can describe patterns and cannot explain them. Influenza and pneumonia are grouped together under shared diagnostic codes, so the analysis cannot separate a flu death from a bacterial pneumonia death. It contains no information about individual vaccination status, smoking history, or underlying conditions.
The Gaps the Data Also Exposed
Beyond age, the analysis found differences that have not closed.
Death rates were consistently higher for men than for women across the entire period, at 43.7 versus 31.4 per 100,000 in 1999 and 19.5 versus 14.2 in 2023. Black adults carried the highest burden in 1999 at 38.7 per 100,000 and saw the largest relative improvement, reaching 19.0 by 2023. Rural counties had higher age-adjusted death rates than metropolitan areas, at 40.0 per 100,000 versus 35.1 at the start of the period, and 23.5 versus 19.3 two decades later.
Adults 85 and older remain by a wide margin the group with the highest crude death rate, which peaked at 751.8 per 100,000 in 1999. The overall improvement did not change who is most at risk. It changed how many of them die. That pattern of unequal gains echoes what MedicalDaily reported in its coverage of federal life expectancy tables, which show nearly 15 years between the longest- and shortest-living US groups.
Steps That Follow From This for a Middle-Aged Adult
Nothing in this study changes any recommendation, and it should not be read as new guidance. It does suggest a question worth raising at a routine appointment for anyone in their late fifties or early sixties.
Pneumococcal vaccination is recommended for adults age 50 and older, and earlier for people with certain chronic conditions or weakened immune systems, according to the CDC's adult immunization schedule. Whether one or two doses apply depends on prior vaccination history, which is a matter of record rather than a judgment call. Annual influenza vaccination is recommended for everyone aged 6 months and older, and updated shots are expected to be available with insurer coverage this season.
Chronic conditions do most of the work in turning a respiratory infection into a fatal one. Blood sugar control, COPD and asthma management, and smoking cessation all reduce the severity of what follows an infection, and all of them are more consequential in this age band than most people assume.
Symptoms that warrant prompt medical attention include fever with a cough that worsens rather than improves, shortness of breath at rest or with light activity, chest pain when breathing, confusion, and a fever that returns after apparently resolving. That last pattern, improvement followed by relapse, is a classic presentation of bacterial pneumonia following influenza and is frequently dismissed as a setback rather than a new problem.
Anyone with a chronic lung condition, heart disease, diabetes, or a weakened immune system should have a lower threshold for calling a clinician, regardless of age.
Key Questions Answered
What did the analysis find? US influenza and pneumonia deaths fell from 63,006 in 1999 to 44,625 in 2023, a 29.2 percent drop. The age-adjusted rate fell from 35.9 to 16.5 per 100,000.
Which group was the exception? Adults aged 55 to 64, the only group with a statistically significant rise in crude death rate, averaging 0.8 percent per year.
Does this mean middle-aged adults are now at higher risk? Not established. The overall decline is age-adjusted, while the 55 to 64 figure is a crude rate, and the aging of a large cohort through that band could account for part of the rise.
What kind of study is this? An observational analysis of CDC WONDER death certificate data. It describes patterns and cannot identify causes, and it includes no data on vaccination status or individual risk factors.
Can flu deaths be separated from pneumonia deaths? Not in this analysis. The two are grouped under shared diagnostic codes, which is a recognized limitation of death certificate research.
Who still faces the highest risk? Adults 85 and older by a wide margin, followed by men over women and rural residents over metropolitan residents across the entire study period.
What should a 58-year-old do? Ask a clinician about pneumococcal vaccination, which is recommended from age 50, confirm annual flu vaccination, and manage chronic conditions that worsen respiratory infections.
